# The Effects of Cannabis Use in People With Schizophrenia on Clinical, Neuropsychological and Physiological Phenotypes

> **NCT01832766** · PHASE1,PHASE2 · TERMINATED · sponsor: **University of Colorado, Denver** · enrollment: 13 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Dronabinol
- **OTHER:** Placebo Comparator

## Key facts

- **NCT ID:** NCT01832766
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-06
- **Primary completion:** 2010-05
- **Final completion:** 2011-05
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Unable to find subjects with schizophrenia that were using only cannabis
- **Last updated:** 2015-09-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01832766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01832766, "The Effects of Cannabis Use in People With Schizophrenia on Clinical, Neuropsychological and Physiological Phenotypes". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01832766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*